Document Detail


Iron and vascular calcification. Is there a link?
MedLine Citation:
PMID:  21325349     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Iron deficiency is frequently seen in patients with end-stage renal disease, particularly in those treated by dialysis, this is because of an impairment in gastrointestinal absorption and ongoing blood losses or alternatively, due to an impaired capacity to mobilize iron from its stores, called functional iron deficiency. Therefore, these patients may require intravenous iron to sustain adequate treatment with erythropoietin-stimulating agents. Aside from this, they are also prone to vascular calcification, which has been reported a major contributing factor in the development of cardiovascular disease and the increased mortality associated herewith. Several factors and mechanisms underlying the development of vascular calcification in chronic kidney diseased patients have been put forward during recent years. In view of the ability of iron to exert direct toxic effects and to induce oxidative stress on the one hand versus its essential role in various cellular processes on the other hand, the possible role of iron in the development of vascular calcification should be considered.
Authors:
Ellen Neven; Tineke M De Schutter; Geert J Behets; Ajay Gupta; Patrick C D'Haese
Related Documents :
21454719 - Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options.
9501269 - Oligosaccharide excretion in adult gaucher disease.
518109 - Non-neuropathic gaucher disease presenting in infancy.
20937139 - Sphingolipids: the nexus between gaucher disease and insulin resistance.
9110139 - Rheumatic manifestations of inherited diseases.
19655269 - Management of neuronopathic gaucher disease: revised recommendations.
19302049 - Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*).
20065899 - Chronic kidney disease: whom to screen and how to treat, part 1: definition, epidemiolo...
15126149 - Endothelial cell activation and hypercoagulability in ocular behçet's disease.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-16
Journal Detail:
Title:  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association     Volume:  -     ISSN:  1460-2385     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-2-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8706402     Medline TA:  Nephrol Dial Transplant     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
1Laboratory of Pathophysiology, Faculties of Medicine and Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Wilrijk, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis p...
Next Document:  Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progressi...